Received Mar 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 5 | T343J | IM / LL |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | TF27T | IM / RL |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Y008234 | SC / LL |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y008284 | OT / LL |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
No adverse effects reported; Improper storage of proquad; This spontaneous report was received from a Registered Nurse and refers to a(n) 5-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Kinrix (Diphtheria vaccine toxoid;Pertussis vaccine acellular 3-component;Polio vaccine inact 3v (Vero);Tetanus vaccine toxoid), Havrix (Hepatitis a vaccine inact) . On 14-Nov-2024, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (rHA) (Oka-Merck) Virus Vaccine Live (lot #Y008284, expiration date: 21-Oct-2025), dose number 1, administered by Subcutaneous route in Left Thigh, for prophylaxis (improper storage of product in use). No adverse effects reported.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : , Index date : 2025-02-26 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : 11/28/2018 , Central date : 2025-02-20 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :
kinrix; Havrix